VANGUARD GROUP INC

Holdings History for Niagen Bioscience, Inc. - Common Stock (NAGE)

Symbol: NAGE on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 3,286,498 shares
Security Ownership %: 4.1%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Niagen Bioscience, Inc. Common Stock (NAGE)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,286,498 shares of Niagen Bioscience, Inc. Common Stock (NAGE). This represents 4.1% ownership of the company. In their previous filing dated 31 Oct 2025, VANGUARD GROUP INC had reported owning 4,021,650 shares, indicating a decrease of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
The Vanguard Group	4.1%	-19%	$20,902,127	3,286,498	-735,152	-18%	$6.36	13G/A	31 Dec 2025	30 Jan 2026, 14:16
The Vanguard Group	5%		$37,521,994	4,021,650			$9.33	13G	30 Sep 2025	31 Oct 2025, 11:03

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$20,902,127	3,286,498	-735,152	-18%	$6.36	Q4 2025
30 Sep 2025	0%	+0%	$37,521,994	4,021,650	+97,083	+2.5%	$9.33	Q3 2025
30 Jun 2025	0%	+0%	$56,553,011	3,924,567	+383,904	+11%	$14.41	Q2 2025
31 Mar 2025	0%	+0%	$24,430,575	3,540,663	+151,116		$6.90	Q1 2025
31 Dec 2024	0%	-0%	$17,981,547	3,389,547	-40,809	-1.2%	$5.31	Q4 2024
30 Sep 2024	0%	+0%	$12,520,799	3,430,356	+43,931	+1.3%	$3.65	Q3 2024
30 Jun 2024	0%	+0%	$9,244,940	3,386,425	+338,306	+11%	$2.73	Q2 2024
31 Mar 2024	0%	0%	$10,607,454	3,048,119	0		$3.48	Q1 2024
31 Dec 2023	0%	0%	$4,358,810	3,048,119	+4,477	+0.15%	$1.43	Q4 2023
30 Sep 2023	0%	0%	$4,443,718	3,043,642	0		$1.46	Q3 2023
30 Jun 2023	0%	-0%	$4,778,518	3,043,642	-84,376	-2.7%	$1.57	Q2 2023
31 Mar 2023	0%	+0%	$4,785,867	3,128,018	+518,823	+20%	$1.53	Q1 2023
31 Dec 2022	0%	+0%	$4,383,448	2,609,195	+377,898	+17%	$1.68	Q4 2022
30 Sep 2022	0%	+0%	$2,744,000	2,231,297	+48,853	+2.2%	$1.23	Q3 2022
30 Jun 2022	0%	-0%	$3,645,000	2,182,444	-598,993	-22%	$1.67	Q2 2022
31 Mar 2022	0%	+0%	$6,842,000	2,781,437	+240,414	+9.5%	$2.46	Q1 2022
31 Dec 2021	0%	-0%	$9,503,000	2,541,023	-90,550	-3.4%	$3.74	Q4 2021
30 Sep 2021	0%	+0%	$16,500,000	2,631,573	+22,936	+0.88%	$6.27	Q3 2021
30 Jun 2021	0%	+0%	$25,721,000	2,608,637	+266,299	+11%	$9.86	Q2 2021
31 Mar 2021	0%	-0%	$21,877,000	2,342,338	-96,218	-3.9%	$9.34	Q1 2021
31 Dec 2020	0%	-0%	$11,705,000	2,438,556	-22,521	-0.92%	$4.80	Q4 2020
30 Sep 2020	0%	+0%	$9,869,000	2,461,077	+203,421	+9%	$4.01	Q3 2020
30 Sep 2020		0%	$2,000	408	0		$4.90 ^*	Q3 2020
30 Jun 2020	0%	+0%	$10,363,000	2,257,656	+52,482	+2.4%	$4.59	Q2 2020
31 Mar 2020		0%	$1,000	192	0		$5.21 ^*	Q1 2020
31 Mar 2020	0%	+0%	$7,189,000	2,205,174	+116,364	+5.6%	$3.26	Q1 2020
31 Dec 2019	0%	+0%	$9,002,000	2,088,810	+200,908	+11%	$4.31	Q4 2019
30 Sep 2019	0%	+0%	$7,429,000	1,887,902	+127,069	+7.2%	$3.94	Q3 2019
30 Jun 2019	0%	0%	$8,188,000	1,760,833	+700	+0.04%	$4.65	Q2 2019
31 Mar 2019	0%	+0%	$7,375,000	1,760,133	+165,618	+10%	$4.19	Q1 2019
31 Dec 2018	0%	+0%	$5,469,000	1,594,515	+22,437	+1.4%	$3.43	Q4 2018
30 Sep 2018	0%	+0%	$6,744,000	1,572,078	+88,125	+5.9%	$4.29	Q3 2018
30 Jun 2018	0%	+0%	$5,505,000	1,483,953	+242,131	+19%	$3.71	Q2 2018
31 Mar 2018	0%	+0%	$5,216,000	1,241,822	+232,771	+23%	$4.20	Q1 2018
31 Dec 2017	0%	+0%	$5,933,000	1,009,051	+30,061	+3.1%	$5.88	Q4 2017
30 Sep 2017	0%	+0%	$4,210,000	978,990	+85,049	+9.5%	$4.30	Q3 2017
30 Jun 2017	0%	-0%	$3,415,000	893,941	-91,331	-9.3%	$3.82	Q2 2017
31 Mar 2017	0%	+0%	$2,651,000	985,272	+39,052	+4.1%	$2.69	Q1 2017
31 Dec 2016	0%	+0%	$3,132,000	946,220	+9,957	+1.1%	$3.31	Q4 2016
30 Sep 2016	0%	+0%	$2,790,000	936,263	+32,011	+3.5%	$2.98	Q3 2016
30 Jun 2016	0%	+0%	$3,744,000	904,252	+904,252	NEW	$4.14	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.